透明质酸结合蛋白1抗体

Quantity size:

0.2ml

Concentration:

1mg/ml  透明质酸结合蛋白1抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The human complement subcomponent C1q associates with C1r and C1s in order to yield the first component of the serum complement system (SCS). The SCS contains over 30 glycoproteins that influence physiological mechanisms of the body in response to immune complex (the classical pathway), carbohydrate (the lectin pathway) or bacterial (alternative pathway) 透明质酸结合蛋白1抗体initiation. C1q binding protein (C1QBP), also designated gC1q-R, p32 (p33) or HABP1 (hyaluronan-binding protein 1), is known to bind the globular heads of C1q molecules and inhibit C1 activation. C1QBP has been described as a complement receptor for C1q on B cells, neutrophils and mast cells. The C1QBP protein may form homodimers. C1QBP is expressed in 透明质酸结合蛋白1抗体vascular endothelial cells and has been found to be a multifunctional protein interacting with elements of complement, coagulation and kinin systems. In addition, C1QBP is a subunit of pre-mRNA splicing factor SF2/ASF.

Also known as:

C1q globular domain binding protein; C1QBP; GC1q R; C1QBP_HUMAN antibody Complement component 1 q subcomponent binding protein; Complement component 1 Q subcomponent binding protein mitochondrial; Complement component 1 Q subcomponent-binding protein, mitochondrial; GC1Q R; GC1q R protein; GC1q-R protein; GC1QBP; GC1QR; Glycoprotein gC1qBP; HABP 1; HABP1;透明质酸结合蛋白1抗体 Hyaluronan binding protein 1; Hyaluronan-binding protein 1; Mitochondrial matrix protein p32; p32 antibody p33 antibody Pre mrna splicing factor SF2 P32 subunit precursor; SF2p32; Splicing factor SF2 associated protein.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human C1QBP.

●

透明质酸结合蛋白1抗体Predicted Molecular Weight: 24kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl079Ra01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)

kl079Rb52白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)

kl079Si01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)

kl081Ga01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Hu01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Mu01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Ra01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl081Si01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)

kl083Hu01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl083Mu01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl083Po01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl083Ra01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)

kl085Bo01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Ca01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Cp01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Hu01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Mu01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Po01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl085Ra01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)

kl086Bo01L选择素(SELL)多克隆抗体Polyclonal Antibody to Selectin, Leukocyte (SELL)

kl086Hu01L选择素(SELL)多克隆抗体Polyclonal Antibody to Selectin, Leukocyte (SELL)